NCT04032704 2025-03-10A Study of Ladiratuzumab Vedotin in Advanced Solid TumorsSeagen Inc.Phase 2 Terminated205 enrolled 54 charts
NCT04234113 2025-01-08Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid TumorsSotio Biotech Inc.Phase 1 Terminated115 enrolled
NCT02963090 2023-02-15Pembrolizumab vs Topotecan in Patients With Small Cell Lung CancerAlliance Foundation Trials, LLC.Phase 2 Terminated9 enrolled 11 charts
NCT02934503 2021-11-16Study of Pembrolizumab and Chemotherapy With or Without Radiation in Small Cell Lung Cancer (SCLC)NYU Langone HealthPhase 2 Terminated5 enrolled 5 charts
NCT03277352 2021-07-22INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic MalignanciesIncyte CorporationPhase 1/2 Terminated10 enrolled 14 charts
NCT03361228 2020-05-21A Study to Evaluate the Safety, Tolerability, and Antitumor Activity of INCB001158 Plus Epacadostat, With or Without Pembrolizumab, in Advanced Solid TumorsIncyte CorporationPhase 1/2 Terminated5 enrolled 4 charts
NCT02331251 2018-07-02Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)Western Regional Medical CenterPhase 1/2 Terminated81 enrolled